← All supplements

Caffeine

Studies disagree — unsettled

A professional body says genetic variation may explain why the same coffee helps one person and keeps another awake. It stops short of telling anyone to test.

What this supplement connects to

Caffeine Variant: rs5751876 · ADORA2A rs5751876 · ADORA2A Variant Variant: rs762551 · CYP1A2 rs762551 · CYP1A2 Variant Topic: Caffeine and energy drinks Caffeine and energy drinks Topic Topic: Blood sugar and insulin Blood sugar and insulin Topic Topic: Running and endurance Running and endurance Topic Caffeine Caffeine Stimulant

Solid lines are connections this site curates. Dashed lines mean the two ends share a research paper — worth knowing, and not a claim that one explains the other.

The International Society of Sports Nutrition's 2021 position stand says that differences between individuals — in performance, and in the sleep and anxiety effects — may be attributed to genetic variation in caffeine metabolism and response. It also names habitual intake as a factor, and it does not recommend genotyping.

CYP1A2 is the enzyme that clears most of a dose. Studies of rs762551 and athletic performance genuinely disagree with each other, and the honest summary is that this is unsettled rather than established.

A second gene, on the receptor rather than the metabolism

Caffeine works by blocking adenosine receptors — which is also what makes it alerting and what disrupts sleep. ADORA2A, the main receptor caffeine acts on, has its own variant: rs5751876. In a study of 2,735 people, the TT genotype grew rarer as habitual caffeine intake rose — the odds of carrying it fell to 0.57 (95% CI 0.42-0.77) among people drinking over 400 mg a day, compared with under 100. A separate, smaller study found the same genotype among people who rated themselves as more sensitive to caffeine's effect on sleep. A newer, smaller study did not reproduce the intake finding — this is unsettled in the same way the CYP1A2 side of this page is.

Marilyn C. Cornelis is the lead author behind both genes' key studies on this page — CYP1A2 in 2006, ADORA2A in 2007 — the same researcher working both sides of the same question a year apart.

Which leaves the obvious test, available to everyone and free: drink a coffee at four in the afternoon and see whether you sleep.

Sources

Papers, with their authors

Questions about Caffeine

What is caffeine?

Caffeine is a stimulant found in coffee, tea and many drinks that blocks adenosine receptors in the brain. A gene called CYP1A2 affects how quickly the body metabolizes it, shaping how it affects sleep and alertness.

Does CYP1A2 genotype tell me how much caffeine is safe for me?

Not reliably — studies of rs762551 and performance genuinely disagree with each other, and no guideline recommends testing before drinking coffee.

What does the ADORA2A variant add that CYP1A2 does not?

CYP1A2 affects how fast caffeine is cleared; ADORA2A is the receptor caffeine actually acts on, so its variant relates to sensitivity and sleep disruption rather than metabolism speed. A large study found the TT genotype grew rarer as habitual intake rose, but a newer, smaller study did not reproduce that finding — unsettled, like the rest of this page.

If a professional body mentions genetics, why does it not recommend testing?

The ISSN's 2021 position stand says differences between people may be attributed to genetic variation, but that is not the same as evidence strong enough to guide one person's dose.

What is the practical alternative to genetic testing for caffeine sensitivity?

A simple, free test available to everyone: drink a coffee at four in the afternoon and see whether you sleep.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Caffeine. MyGeneLog™. https://www.mygenelog.com/supplements/caffeine

Nothing on this page recommends taking anything. If a result here matters to you, take it to a doctor or a pharmacist rather than to a shop.